6 studies on Ghrh agonist mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research suggests that GHRH agonists like sermorelin and its more potent analogs could be a powerful therapeutic tool for improving recovery after a heart attack. For biohackers or clinicians exploring regenerati…
This study provides compelling evidence in a large animal model that GHRH agonists like the Sermorelin analog MR-409 can directly target the heart to promote structural repair after a heart attack. The significant red…
The findings position the GHRH analog **MR-409** as a potent mitogenic and anti-apoptotic agent for skin cells, suggesting it could be a valuable tool for enhancing tissue repair. For clinicians and individuals dealin…
These findings suggest that GHRH analogs like sermorelin may have beneficial effects on mood beyond their established roles, potentially by directly modulating neuroinflammation and monoamine neurotransmitter systems …
These findings suggest GHRH agonists could be a novel and effective therapy for **heart failure with preserved ejection fraction (HFpEF)**, a condition with few treatment options. For clinicians and researchers, this …
These findings suggest a novel therapeutic avenue for optic neuropathies like glaucoma. While both GHRH agonists and antagonists showed some neuroprotective effects, the agonist **MR-409** uniquely synergized with the…